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Abstract
Transplantation of adipose-derived mesenchymal stem cells (ASCs) induces tissue regeneration by accelerating the growth
of blood vessels and nerve. However, mechanisms by which they accelerate the growth of nerve fibers are only partially
understood. We used transplantation of ASCs with subcutaneous matrigel implants (well-known in vivo model of
angiogenesis) and model of mice limb reinnervation to check the influence of ASC on nerve growth. Here we show that
ASCs stimulate the regeneration of nerves in innervated mice’s limbs and induce axon growth in subcutaneous matrigel
implants. To investigate the mechanism of this action we analyzed different properties of these cells and showed that they
express numerous genes of neurotrophins and extracellular matrix proteins required for the nerve growth and myelination.
Induction of neural differentiation of ASCs enhances production of brain-derived neurotrophic factor (BDNF) as well as
ability of these cells to induce nerve fiber growth. BDNF neutralizing antibodies abrogated the stimulatory effects of ASCs
on the growth of nerve sprouts. These data suggest that ASCs induce nerve repair and growth via BDNF production. This
stimulatory effect can be further enhanced by culturing the cells in neural differentiation medium prior to transplantation.
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Introduction
Recently, cell therapy has been proposed as an efficient method
for regenerating injured nerves [1]. Transplantation of Schwann
cells or stem cells of various origins, which differentiate towards
Schwann cell-like phenotype, stimulate peripheral nerve repair.
Transplanted cells stimulate the growth and myelination of nerve
sprouts by secreting neurotrophins and neuroregulins together
with components of myelin shell [2].
However, obtaining Schwann cells for autologous transplan-
tation is highly traumatic and these cells are difficult to expand
in vitro [3]. Therefore, there is a need for a more easily
accessible source of cells that are capable of stimulating nerve
sprout growth and repair. Adipose-derived stem cells (ASCs) can
be easily obtained and expanded in vitro for use in autologous
cell therapy. Thus, transplanted ASCs stimulate blood vessel
growth in vivo [4,5]. This effect is dependent on the secretion of
growth factors, VEGF, HGF and bFGF, and enhanced by
exposing the cells to hypoxia. The ability of ASCs to stimulate
the growth of nerve sprouts in ischemic myocardium has recently
been demonstrated [6]. Furthermore, nerve conduits seeded with
ASCs differentiated towards Schwann-like cell phenotype and
promote peripheral nerve repair. However, mechanisms of
ASC’s action on nerve regeneration are only partially under-
stood. This can be addressed using in vivo models of nerve injury
and growth in conjunction with determining gene expression
patterns in the cells.
In this study we tested the hypothesis that ASCs stimulate repair
of crushed peripheral nerves and induce nerve sprout growth by
producing neurotrophic growth factors as well as myelin sheath
components. Since the ability of ASCs to prevent hypoxia-induced
brain injury is dependent on BDNF production [7], we also
examined the impact of this neurotrophin on nerve fiber growth
induced by ASCs.
Materials and Methods
Ethics statement
Written consent has been given from the patients for their
information to be stored in the hospital database and used for
research. The use of tissue was approved by the corresponding
Ethics Committees of the Faculty of Fundamental Medicine and
Cardiology Research Center. Freshly excised clinical specimens
included in this study were collected from consenting patients
undergoing surgical treatment at Cardiology Research Center.
Animal studies were conducted according to Institute of
Experimental Cardiology approved guidelines, as well as guide-
lines approved by the Institutional Animal Care and Use
committee of Cardiology Research Center (permit number
385.06.2009).
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We used 8–9 week old C57Bl6-GFP transgenic and C57Bl6
male mice as a source of mouse ASCs (mASCs) and also for the
matrigel transplantation experiments. F1 offspring of CBA/
C57Bl6 mice were used for the nerve injury model. Animals were
anesthetized by i.p. injection of avertin before experimental
manipulations.
Cell Isolation, Culture and Stimulation
Human (h) ASCs were isolated from adipose tissue obtained
from 15 female donors during abdominal surgery [8]. All donors
gave their informed consent and the local ethics committee
approved the study protocol. Mouse subcutaneous adipose tissue
was obtained from the inguinal region and cells isolated by enzyme
digest. Cells were cultured in AdvanceSTEM Mesenchymal Stem
Cell Media containing 10% AdvanceSTEM Supplement (Hy-
Clone), 1% antibiotic–antimycotic (HyClone) at 37uC in 5% CO2
incubator. Cells were passaged to 70% confluency using HyQT
ase solution (HyClone). For the experiments, cells of the second
passage were used.
Recently we and others showed that hypoxia up-regulates
expression of growth factors by ASCs [9]. Hypoxia was induced by
culturing serum-deprived cells in a hypoxic incubator (48R, New
Brunswick) at 37uC, using 5% CO2 and 1% O2 for 48 hours. Cell
cultured in hypoxia conditions are identified as hypASCs for
mouse ASCs and hyp_hASCs for human ASCs. Induction of
neural differentiation was performed using retinoic acid, a well
known inducer of neural differentiation [10]. mASCs or hASCs at
40–60% confluence were placed in neural differentiation medium
(AdvanceSTEM Mesenchymal Stem Cell Media containing 3%
AdvanceSTEM Supplement (HyClone), 1% antibiotic–antimycot-
ic (HyClone), 1 mM 5- azacytidine and 1 mM retinoic acid) for
72 hours. Cells stimulated towards neural differentiation are
referred to as indASCs for mouse ASCs and ind_hASCs for
human ASCs.
Nerve injury model
The common peroneal nerve (n. peroneus communis) was isolated
from surrounding tissue under sterile conditions and crushed using
1-mm-wide needle holder with silicone coated branches 3 times for
20 seconds [11–13]. mASCs suspended in matrigel matrix (70 ml)
were applied over injured nerve. Mice were divided into three
experimental groups: a negative control group, which received
matrigel without cells (n=14); a mASC treatment group, which
received matrigel with 16106 of mASCs (n=14); and a positive
control group, which received matrigel without cells but
administered 65 mg/kg vitamin B12 i.p. every day after surgery
(n=14) [14]. After matrigel polymerization the wound was closed.
Then the effect of mASC implantation on functional nerve
recovery was assessed. Motor nerve recovery was analyzed 1, 2, 4,
7 and 11 days after surgery using the peroneal function index (PFI)
[15,16]. Mouse hind paws were stained with ink and animals were
allowed to run along a tunnel, 6650 cm. Footprint images were
scanned and footprint width and length measured using
Metamorph 7.1 software. PFI was calculated using the following
formula: PFI=174.9*(EPL2NPL)/NPL+80.3*(ETS2NTS)/
NTS213.4; where EPL and ETS are footprint length and width,
respectively, measured 1, 2, 4, 7 or 11 days after injury; and NPL
and NTS are footprint length and width, respectively, measured
before injury [17]. Sensory nerve recovery was analyzed 7 and 11
days after surgery using electrophysiological parameters on the
superficial branch of common peroneal nerve (n. peroneus super-
ficialis). Mice were sacrificed with anesthetic overdose (7 animals
from each group after performing walking track analysis 7 and 11
days after injury). The superficial branch of common peroneal
nerve was isolated and stimulated in Laily solution 7–8 mm
proximal from injury site (frequency 1 Hz, impulse length 0.05 ms
and supramaximal stimulus amplitude 2.5–10 V) using a pair of
silver electrodes, (distance between electrodes 1.5 mm). The
waiting period in-between scarification of the animals and
measurement of nerve conduction velocity was standard (35–
45 minutes) for all the animals. The length of latency period and
amplitude of total nerve action potential were recorded 3 times for
each nerve using a monopolar aspirating electrode (10 mm distal
from injury site) connected to AD-converter and output analyzed
using PowerGraph Professional 3.3 software (Figure S1).
The effect of mASCs on nerve healing was then confirmed.
Myelin sheaths of healing nerve were analysed using Sudan black
staining as described elsewhere [18]. Briefly, frozen sections of
peripheral nerve were fixed by 0.4% potassium dichromate,
pH 3.5 for 18 hrs at 56uC. Then sections were stained by 0.1%
Sudan Black B (Merck) in 70% ethanol for 5 min at room
temperature, washed by 50% ethanol, dehydrated and mounted in
Depex medium (Merck). The number of axons was evaluated on
formalin-fixed frozen sections using immunofluorescent staining
with rabbit anti-neurofilament 200 antibody (Abcam, 8135) (see
Immunofluorescent staining… section below for details). Alexa 488-
conjugated anti-rabbit antibody (Molecular Probes) was the
secondary antibody. Nuclei were counterstained with 4-, 6-
diamidino-2-phenylindole (DAPI) (Molecular Probes). Rabbit
non-specific IgG was used as a negative control. Images were
obtained using Leica6000 microscope equipped with CCD camera
(Leica Microsystems).
Matrigel Implantation into Mice
The effect of ASCs on axon growth in vivo was assessed using
matrigel subcutaneous implant. This method was widely used for
assessment of blood vessels growth [4] [19]. Since blood vessels
and nerves grow simultaneously, we used this model for studying
axon growth. Mice were anesthetized by i.p. injection of 2.5%
avertin solution. We mixed 400 ml of ice-cold growth factor
reduced matrigel matrix (BD Biosciences) with 7610
5 mASCs in
50 ml of AdvanceSTEM Mesenchymal Stem Cell Media (Hy-
Clone) and injected obtained suspension subcutaneously into the
right and left sides of the mouse’s back using insulin syringe with a
23G needle. Injections were performed slowly allowing matrigel to
polymerize and form a jelly-like implant with an irregular shape
under the skin. We used four different matrigel preparations: one
with growth media only (no cells; negative control; n=9); one
containing mASCs cultured in normoxic conditions (norm_
mASCs; n=9); another with mASCs cultured in hypoxic
conditions (hyp_mASCs; n=9) and one containing mASCs,
which have been cultured in neural differentiation medium prior
to incorporation into matrigel (ind_mASCs; n=9). These were
randomized so that each mouse was implanted with two different
matrigel preparations (e.g. one from the negative control
preparation and one containing normoxic mASCs). A total of 18
mice received the matrigel implants. Ten days after injection, the
mice were killed with an anesthetic overdose and perfused with
formalin. Entire matrigel plugs were then isolated, weighted,
embedded in O.C.T. compound (Sakura Inc) and frozen in liquid
N2. To determine whether BDNF contributes to the effects of
mASCs on nerve fiber growth, we also implanted into 5 mice
matrigel containing mASCs plus non-immune IgG (10 mg/ml) and
matrigel containing mASCs plus BDNF neutralizing antibodies
(10 mg/ml), one implant of each per mouse, which were examined
10 days later.
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analysis of nerve fiber density
Nerve fibers in matrigel were detected by immunofluorescent
staining using antibodies to nerve marker proteins GAP43 (Abcam,
cat # ab12274), neurofilaments 200 (Sigma, cat # 4142),
peripherin (Abcam, cat # 4666) and tyrosine hydroxylase (Abcam,
cat # 112). Alexa 594-conjugated anti-rabbit antibody (Molecular
Probes) was the secondary antibody. Nuclei were counterstained
with 4-, 6-diamidino-2-phenylindole (DAPI) (Molecular Probes).
For negative controls rabbit non-specific IgGs were used. Images
were obtained using Leica6000 microscope equipped with CCD
camera (Leica Microsystems). Quantitation of nerve fiber density
and length was performed on 6 frozen sections from each matrigel
implant using immunofluorescence of the nerve growth marker
protein GAP43 [20,21]. Nerve length and density were evaluated
using MetaMorph 7.1 (Molecular Devices) as described earlier [22].
RNA extraction from ASC, RT-PCR and real-time PCR
Analysis
To determine how culture of ASCs in hypoxic conditions and
differentiation media affects expression of neurotrophins, total
cellular RNA was isolated from mASCs or hASCs using RNeasy
Kit (Qiagen, cat # 74104) following by a reverse transcription
reaction using a Reverse Transcription kit (Fermentas, cat #
K1611). Real-time polymerase chain reactions (PCR) were
performed using a SYBR Green PCR Master Mix (Fermentas,
cat # K0221) and the Multicolor Q5 (Bio-Rad). PCR reactions
were performed using 50 ng of cDNA and 100–500 nmol/L of
each primer. For all reaction the thermal cycling parameters were:
10 minutes at 95uC followed by 40 cycles of 15 seconds at 95uC
for denaturation, 20 seconds at empirically adjusted temperature
for each primer to anneal and 20 seconds at 72uC to extend. We
used following oligonucleotide primers for PCR analysis of gene
expression in hASCs: beta-actin for CCTGGCACCCAGCA-
CAAT, beta-actin rev GGGCCGGACTCGTCATAC; GAPDH
for TGCACCACCAACTGCTTAGC, GAPDH rev GGCATG-
GACTGTGGTCATGAG; VEGF for CAACATCACCATGCA-
GATTATGC (60.2uC), VEGF rev CCCACAGGGATTTTC-
TTGTCTT (60.2uC); BDNF2 for GTAGTCTTCTTGGCC-
CCGCTGTAA (59.6uC), BDNF2 rev AACGCTCCGCTCC-
AAAATCTGA (59.7uC); GDNF1 for GCTGTCTGCCTGGT-
GCTGCTC (59.6uC), GDNF1 rev GCCTGCCGATTCCGC-
TCTC (59.3uC); NGF for AGGGAGCAGCTTTCTATCCTG
(61uC), NGF rev GGCAGTGTCAAGGGAATGC (61.1uC). We
used following oligonucleotide primers for PCR analysis of gene
expression in mASCs: beta-actin for AGTGTGACGTTGA-
CATCCGTA, beta-actin rev GCCAGAGCAGTAATCTCCTT-
CT; GAPDH for GACCCCTTCATTGACCTCAACTAC,
GAPDH rev TGGTGGTGCAGGATGCATTGCTGA; VEGF
for GCAAAACACTCACCATTCCCA (60.2uC), VEGF rev GA-
GGTTTGAAATCGACCCTCG (60uC); BDNF2 for TTTG-
CGGCATCCAGGTAATTT (59.6uC), BDNF2 rev CCATAAG-
GACGCGGACTTGTA (59.7uC); GDNF1 for CCAGTGACTC-
CAATATGCCTG (60uC), GDNF1 rev CTCTGCGACCTTT-
CCCTCTG (59uC); NGF for GCACTACACCCATCAAG-
TTCA (61.5uC), NGF rev TCCTGAGTCATGCTCACAAGT
(61.1uC). All measurements were performed in triplicates. Levels
of expression were normalized to the expression of 2 house-
keeping genes GAPDH and beta-actin.
Transcriptome analysis
To determine whether ASCs express neurotrophins and matrix
components required for axonal growth, we performed gene array
experiments using cultured hASCs. Five hundred nanograms of
total RNA was labeled and hybridized on HumanHT-12 v4
Expression BeadChip (Cat. no. BD-103-0204; Illumina, San
Diego, CA, USA), according to the manufacturers recommenda-
tions (Illumina Gene Expression Profiling Assay Guide). Bead-
Chips were scanned with the Illumina iScan Reader. Data were
imported into GenomeStudio (Illumina) and analyzed.
Measurement of BDNF Secretion by ELISA
hASCs were cultured in serum-free medium under hypoxic
conditions, or in the presence of 5-azacitidin or 5-azacitidin plus
retinoic acid for 2 days, then medium was collected and the
concentration of BDNF in the media determined using a BDNF
ELISA kit (Millipore, cat #GYT306), following the manufacturer
instructions.
Statistical Analysis
Data was assessed for normality of distribution using the
Kolmogorov-Smirnov test. Statistical analysis was performed using
SigmaPlot11.0 Software. Differences between treatment and
control groups were then analyzed using Student t-test or the
Mann-Whitney U-test, depending whether it was normally
distributed or not. Data are expressed as mean 6 SEM or
median (25%; 75%) depending on the test used. We considered
differences to be significant when p,0.05.
Results
ASCs can induce tissue regeneration and were suggested as
potent candidates for cell therapy. To assess their action on nerve
growth and repair we have employed in vivo models accompanied
by expression analysis of genes involved in the regulation of axonal
growth and myelination.
mASCs stimulate repair of injured nerves
Application of mASCs to the injury site of common peroneal
nerve accelerated functional recovery of motor and sensory nerves.
The extensor muscles of the toes exhibited improved function in
animals treated with mASCs comparing to negative controls,
reflecting improved activity of respective motor neurons. As early
as 2 days after injury, peroneal functional index (PFI) [15] of the
injured limbs of animals treated with mASCs was greater
comparing to negative controls (280.4 (288.2; 274.7), n=84
vs. 2110.5 (2115.8; 2106.0), n=84; p,0.001), and also positive
controls (2109.8 (2121.7; 2106.5), n=84; p,0.001), indicating
faster recovery of motor nerves exposed to an ASCs (Figure 1A).
The PFI of injured limbs of animals treated with mASCs was also
greater compared to negative control group and positive control
group 4 days after injury (238.5 (267.1; 228.5), n=84 vs. 274.9
(280.1; 257.3), n=84, p#0.001; and 282.8(287.3; 273.4),
n=84, p#0.001, respectively). Despite PFI of mice treated with
mASCs was greater compared to negative control group 7 days
after injury (242.8 (248.0; 216.1), n=84, vs. 265.2 (266.7;
264.5), n=84, p#0.001) it did not differ from positive control
group (244.0 (254.1; 237.9), n=84, p=0.075).
We also observed significant recovery of the action potential
amplitude together with a reduction in the latency period of
sensory neurons of common peroneal nerve in mice treated with
mASCs (Figure 1B, C). Action potential amplitude of the
superficial branch of common peroneal nerve in animals treated
with mASCs 7 days after injury was 3.7-fold and 2-fold greater
compared to negative control group and positive control group
(0.82 (0.39;0.92), n=21 vs. 0.22 (0.15; 0.29), n=21, p#0.001 and
0.42 (0.36; 0.45), n=21, p#0.001, respectively). This suggests
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This effect was sustained 11 days after injury. The latency period
of the nerve treated with mASCs 7 days after injury was 1.7-fold
and 1.3-fold shorter compared to negative control group and
positive control group (1.07 (0.97; 1.11), n=21 vs. 1.7(1.65; 2.1),
n=21, p#0.001 and 1.30(1.27; 1.4), n=21, p#0.001 respective-
ly). This indicates better myelination of nerve fibers and greater
thickness of nonmyelinated nerve fibers. However, the difference
of the latency period of nerve conduction velocity between
treated animals and negative control was less prominent 11 days
after injury (1.09 (1.07; 1.23), n=21 vs. 1.46 (1.34; 1.51), n=21,
p,0.05).
Figure 1. Recovery of common peroneal nerve functioning after mASCs transplantation. A.– peroneal function index (PFI) recovery
(motor nerve functioning). B, C. – recovery of nerve conduction velocity (sensory nerve functioning): B. – action potential amplitude; C. - latency
period. * - p,0.05.
doi:10.1371/journal.pone.0017899.g001
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myelin sheaths in nerves treated with mASCs 7 days after injury
(Figure S2), which confirm functional data and indicate that
mASCs application accelerates nerve healing.
mASCs stimulate nerve fiber growth in matrigel implants
in vivo
Because mASCs enhanced repair of damaged nerves, we next
assessed whether they might stimulate nerve fiber growth. The
ability of mASCs to stimulate nerve fiber growth was assessed in
matrigel implants. Ten days after transplantation matrigel
implants contained rare structures expressing the marker nerve
growth cone GAP43 (Figure 2A). The transplantation of mASCs
elevated nerve fiber density in matrigel implants. The number of
GAP43-positive structures was 3.4-fold greater in implants
containing norm_mASCs compared to negative control group
(36.2761.98, n=54 vs. 10.7661.27, n=54, p=0.008; Figure 2B,
F). The total length of observed structures was also 3.1-fold greater
in implants containing norm_mASCs compared to negative
control group (39.9362.38, n=54 vs. 12.9161.52, n=54,
p,0.001; Figure 2B, G). Nerve fiber length in matrigel implants
containing pre-stimulated cells was even greater, 1.3-fold in
implants containing hyp_mASCs (50.4362.03, n=54, p=0.045
vs. norm_mASCs; Figure 2C, G) and 1.8-fold in implants
containing ind_mASCs (72.6261.8, n=54, p=0.007 vs. norm_
mASCs; Figure 2D, G).
To confirm that mASCs stimulated the growth of nerve fibers
expressing GAP43, we analyzed the expression of additional
peripheral nerve markers in the matrigel implants. The matrigel
implants contained structures expressing axonal cytoskeleton
protein, neurofilament 200, intermediate filament subunit con-
centrated in processes of peripheral ganglia neurons, peripherin,
and tyrosine hydroxylase, an enzyme involved in the biosynthesis
of noradrenalin in sympathetic neurons (Figure 3). These
structures were derived from peripheral nerves innervating the
skin and muscles adjacent to the matrigel implants. During the
waiting period (10 days) after subcutaneous implantation of
matrigel there was some reduction in the matrigel gel plugs but
it was never more than 20% and similar for all the treatment
groups (p for differences .0.05). At this time mASC numbers in
the matrigel were 10% of those originally implanted and were
viable. Also, we found no evidence to support possible in vivo
differentiation of the mASCs into neural lineage cells. mASCs
from GFP transgenic mice in matrigel implants did not colocalise
with GAP43, NF200, S100 or GFAP detected by immunofluo-
rescence (not shown).
hACSs express neurotrophins and matrix components
required for axonal growth
Analysis of 24,500 transcripts revealed that hASCs expressed
10,995 known transcripts (p,0.05). About 200 of these transcripts
encoded for specific neurogenesis-related proteins including
enzymes, cytoskeleton proteins and adhesion molecules. Impor-
tantly, hASCs and mASCs (not shown) expressed mRNAs
encoding neurotrophins and neuregulins, including BDNF,
NGF, NENF, GDNF and neuregulin 1, suggesting that these
cells could be the source of neurotrophins at the site of injury.
Furthermore, hASCs expressed neurite guidance molecules such
as netrins and ninjurin 2 as well as extracellular matrix proteins
such as laminins. Importantly, hASCs expressed myelination
master-gene Krox20 (Egr2) together with transcripts encoding
components of peripheral myelin, including proteolipid protein 1,
peripheral myelin protein 22, periaxin, 3 transcript variances of
myelin basic protein as well as myelin proteins zero-like 1 and 2
(for details see Table S1).
Hypoxia and culturing in neural differentiation induction
medium up-regulated the expression of neurotrophins in hASCs.
Hypoxia elevated BDNF mRNA by 50% and NGF by 25%, but
did not affect the expression of GDNF (Figure 4A). The incubation
of hASCs in neural differentiation induction medium caused even
greater up-regulation of neurotrophin expression. In contrast to
hypoxia, neural differentiation medium did not elevate the
expression of VEGF (Figure 4A). We evaluated how hypoxia
and neurogenic induction medium affected the secretion of the
neurotrophic factor, BDNF. Surprisingly, hypoxia did not affect
BDNF secretion by hASCs. In contrast, culture medium from
hASCs treated with 5- azacytidin plus retinoic acid contained up
to 10-fold more BDNF compared to control (2265 ng/ml, n=9
vs. 361.2 ng/ml, n=9; p,0.001).
BDNF takes part in the stimulation of nerve fiber growth
To determine if the observed stimulation of nerve fiber growth
was dependent on BDNF production by ASCs, mASCs were
suspended in matrigel together with 10 mg/ml of a rabbit
polyclonal BDNF neutralizing antibody or non-specific rabbit
IgG and then implanted into mice. 10 days later we assessed the
density of nerve fibers in the implants. Total length of nerve fibers
in the matrigel implants containing mASCs and BDNF neutral-
izing antibodies was about 9 times smaller compared to implants
with cells mixed with non-specific IgGs (3.460.9, n=30 vs.
30.765.2, n=30; p,0.001) (Figure 5).
Discussion
Our study demonstrates that transplantation of mASCs induces
peripheral nerve repair and activates nerve sprout growth in vivo.
Also examination of gene expression profile of mASCs and hASCs
indicated that these cells produce neurotrophic factors and myelin
sheath components, which are necessary for nerve sprout
outgrowth and myelination. Our study demonstrates that ability
of mASCs to stimulate the growth of nerve sprouts depends on
BDNF secretion.
Transplantation of mASCs induces the growth of blood vessels
and nerve sprouts in ischemic myocardium, stimulating regener-
ation [6]. ASCs differentiated towards Schwann-like cell pheno-
type also promote neurite outgrowth [23]. Furthermore, nerve
conduits seeded with such cells enhance myelination [24] and
repair of peripheral nerve [6]. Here we demonstrate that mASCs
affect the growth of tyrosine hydroxylase expressing sympathetic
nerve sprouts. Furthermore, mASCs transplantation stimulated a
functional recovery of crushed sensory and motor neurons,
indicating that this effect is common for all nerve fibers rather
than selective for particular type of neurons. In addition, nerves
treated with mASCs exhibited faster structural recovery. One
explanation for those effects is their ability to produce growth
factors, such as VEGF, bFGF and HGF together with neurotro-
phins, BDNF, NGF, GDNF and NT-1 [7,25,26]. Neurotrophins
stimulate nerve fiber growth and regeneration in several ways:
they directly accelerate axonal growth via PI-3K or PLC-c -
dependent signaling pathways [27,28]; act as positive guidance
molecules for axonal growth cone, prevent apoptosis and induce
proliferation of Schwann cells. Furthermore, ASCs can elevate
neurotrophins production indirectly at the injury site by
stimulating the growth of new blood vessels. Vascular cells
produce BDNF and artemin (ARTN), a neurotrophin of GDNF
family, which attract growing sympathetic nerve fiber and
simultaneously promote nerve fiber formation along the blood
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PLoS ONE | www.plosone.org 5 March 2011 | Volume 6 | Issue 3 | e17899Figure 2. GAP43-positive nerve fibers in matrigel. A–D. - Immunofluorescent staining of frozen sections of matrigels with GAP43 antibodies
(red fluorescence). A. – matrigel with growth media only (no cells; negative control). B. – matrigel containing mASCs cultured in normoxic conditions
(norm_mASCs). C. - matrigel with mASCs cultured in hypoxic conditions (hyp_mASCs). D. - matrigel containing mASCs which have been cultured in
neural differentiation medium prior to incorporation into matrigel (ind_mASCs). E. – frozen matrigel sections stained with non-specific IgGs. F. –
density of nerve fibers (pieces) per section. G. – total length (relative units) of nerve fibers. * - p,0.05.
doi:10.1371/journal.pone.0017899.g002
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injury site by transplanted ASCs could be responsible for a long-
term effect of those cells.
We demonstrate that hypoxia further increases the ability of
ASCs to stimulate the growth of nerve fibers. This reconciles our
previous observations that low-oxygen conditions up-regulate their
angiogenic capabilities and supports the idea that ASCs trans-
plantation induces the simultaneous growth of nerve sprouts and
blood vessels. Indeed, we found that in matrigel implants GAP43
positive nerve fibers which co-localized with lectin-positive blood
Figure 3. Expression of peripheral nerves markers in matrigel after mASCs transplantation. A–E. - Immunofluorescent staining of frozen
matrigel sections with antibodies against neurofilament200 (A.), GAP43 (B.), tyrosine hydroxylase (C.), peripherin (D) or with non-specific IgGs (red
fluorescence). Nerve fibers are indicated by arrows. Nuclei are counterstained with DAPI (blue fluorescence).
doi:10.1371/journal.pone.0017899.g003
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also increased the ability of ASCs to stimulate nerve fiber growth.
Hypoxia and neural differentiation enhance the paracrine activity
of ASCs [4,9,25,30]. We show that low oxygen up-regulates
angiogenic growth factors with modest effects on neurotrophins,
and the combination of retinoic acid with 5-azacytidin further
stimulates expression of neurotrophins and their secretion without
influencing VEGF. Among the neurotrophins produced by ASCs,
BDNF is likely to play the important role. However, we observed
changes in BDNF secretion only in ASCs incubated in
differentiation medium, whereas when the cells were cultured
under hypoxic conditions we found only an increase of BDNF
mRNA. This observation might be explained by the fact that
production of BDNF protein is regulated at the level of translation.
Thus, the long BDNF 39UTR has been reported as a bona fide cis-
acting translation suppressor of BDNF mRNA [31]. Furthermore,
BDNF translation is also regulated by microRNA, e.g. miR-30a-
5p targets specific sequences surrounding the proximal polyade-
nylation site within BDNF 39-untranslated region and overexpres-
sion of this miR results in down-regulation of BDNF protein [32].
Thus, prevention of hypoxia-induced brain damage by condi-
tioned medium from ASCs has been attributed to BDNF secretion
[7]. Furthermore, adenoviruses encoding BDNF have been used to
stimulate axonal regeneration [33]. We demonstrate that the
ability of ASCs to up-regulate nerve sprouts growth correlates with
their production of BDNF and that anti-BDNF neutralizing
antibodies abrogated their stimulatory effect, indicating that
BDNF is an important mediator of ASCs actions. Growing nerve
sprouts migrate along specific matrix components, including
laminins [34]. Just like bone marrow-derived MSCs, ASCs also
express several genes of the laminin family, indicating that these
cells can directly support growing nerve sprouts [35]. Thus, ASCs
play a role analogous to Schwann cells at sites of transplantation.
Interestingly, transcriptome analysis revealed the expression of
Figure 4. Neurotrophin expressions by hASCs. A.- Real-time PCR analysis of neurotrophin mRNAs expressions in hASCs cultured in standard
conditions (norm_hASCs, grey columns), in hypoxia (hyp_hASCs, black columns) or neural differentiation medium (ind_hASCs, hatched columns). B. –
ELISA of BDNF level in conditioned medium of hASCs cultured in standard conditions (grey columns), in hypoxia (black columns) or neural
differentiation medium (hatched columns). *-p,0,05 compared to control.
doi:10.1371/journal.pone.0017899.g004
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neurofilament 150. Furthermore, these cells appeared to express
myelination master-gene Krox20 [36] and its transcriptional
targets, major components of myelin sheath [37]. While this
manuscript was in preparation a study was published showing that
MSCs derived from bone marrow and adipose tissue express
mRNAs encoding several myelin components and co-culture with
neural cells stimulates the secretion of these proteins [38]. Our
functional and histological data suggest that faster healing of
crushed common peroneal nerve is due at least in part to
restoration or protection of the myelin sheath by mASCs
application. Either contact with injured nerves or neural
differentiation medium triggers the myelination program by
ASCs. The reason as to why ASCs exhibit an expression profile
similar to Schwann cells might be due to their similar embryonic
origin [39]. This clearly requires further study.
Taken together, our data suggest that ASCs similar to Schwann
cells can provide neurotrophic growth factors to injured nerves
and improving their re-myelination. Incubation in hypoxic
conditions or in neural differentiation medium prior to transplan-
tation increases their regenerative potential, which depends on the
production of neurotrophins, particularly BDNF. Therefore, ASCs
might be a useful cell therapy for regeneration of injured
peripheral nerves and their re-myelination.
Supporting Information
Figure S1 Design of nerve injury model. A – photography
of n. peroneus communis separated from surrounding tissue before
injury. B - photography of n. peroneus communis injury site. C. -
scheme of nerve conduction velocity assessment.
(TIF)
Figure S2 Common peroneal nerve healing 7 days after
injury. A–D. - Immunofluorescent staining of frozen sections with
NF-200 antibody (green fluorescence). E–H. - Staining of frozen
sections with Sudan black (blue color). A, E. – uninjured nerve. B,
F. – injured nerve treated with matrigel only (no cells; negative
control). C, G. – injured nerve treated with mASCs. D, H. -
injured nerve with matrigel only but administered 65 mg/kg
vitamin B12 i.p. (positive control).
(TIF)
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